Table 2.
Comparison between the different OCT parameters in both groups.
| OCT (μm) Mean ± SD |
Chloroquine group | Control group | p value∗ |
|---|---|---|---|
| CFT | 238.15 ± 22.5 | 248.2 ± 19.05 | 0.034 |
| Parafoveal thickness | |||
| Superior | 310.7 ± 21.64 | 322.35 ± 12.02 | 0.004 |
| Inferior | 309.05 ± 18.75 | 319.025 ± 11.3 | 0.005 |
| Nasal | 311.45 ± 14.9 | 320.05 ± 11.39 | 0.005 |
| Temporal | 299.025 ± 21.67 | 320.05 ± 11.39 | 0.013 |
| Perifoveal thickness | |||
| Superior | 287.675 ± 19.9 | 286.7 ± 11.85 | 0.791 |
| Inferior | 279.1 ± 17.75 | 282.75 ± 10.34 | 0.264 |
| Nasal | 287.38 ± 15.82 | 302 ± 11.4 | 0.107 |
| Temporal | 278.15 ± 20.6 | 282.6 ± 12.144 | 0.243 |
| RNFL thickness | 111.4458 ± 14.6969 | 107.6425 ± 11.5335 | 0.202 |
| GCC thickness | 95.61 ± 6.385 | 96.1217 ± 6.1347 | 0.716 |
| FLV | 0.86 ± 1.04 | 0.60 ± 0.53 | 0.167 |
| GLV | 4.28 ± 3.87 | 3.56 ± 3.05 | 0.358 |
∗Independent samples t-test.